{
  "docId": "019dd923-5ca1-7489-b639-45501f4b359b",
  "docSlug": "158df8627a0b9aca",
  "documentTitle": "Opioid Conflicts Majority Staff Report",
  "authorId": "McKinsey",
  "authorName": "U.S. House Committee on Oversight and Reform",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.773,
  "pageNumber": 31,
  "pageCount": 53,
  "prevPage": 30,
  "nextPage": 32,
  "slideType": "case_study",
  "function": "illustrate_case",
  "density": "dense",
  "nDataPoints": 1,
  "notes": "The slide includes an excerpt from an email sent by McKinsey partners to a client, highlighting their strategy to win business.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "screenshot",
    "callout_box",
    "footnote"
  ],
  "metadataConfidence": 0.95,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5ca1-7489-b639-45501f4b359b/31",
  "deckHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b",
  "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b.json",
  "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b#slide-31",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "We believe McKinsey brings an unequaled capability based on who we know and what we know.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-cdec-74db-b49c-68efbff584eb",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.28,
        "w": 0.7,
        "x": 0.15,
        "y": 0.45
      },
      "kind": "image",
      "text": "Email excerpt from McKinsey partners to Mark Timney",
      "attrs": null,
      "subkind": "screenshot",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "346a5ad0-adc3-4663-bee2-90cdd6f6ec52",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.7,
        "x": 0.15,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "McKinsey appears to have touted its FDA experience directly to Purdue’s CEO in order to obtain additional consulting business. In 2014, Purdue hired Mark Timney as its new CEO. On January 23, 2014, after a breakfast meeting with Mr. Timney, McKinsey partners Rob Rosiello and Arnab Ghatak sent a follow-up email to Mr. Timney emphasizing key points from their meeting, including how McKinsey's public sector connections could benefit Purdue:",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "352825eb-cc54-42bd-84ba-b4ab4e26a4e7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.7,
        "x": 0.15,
        "y": 0.79
      },
      "kind": "paragraph",
      "text": "At the time this email was sent, McKinsey was pitching Purdue on an $800,000 project to support Purdue’s efforts before an FDA Advisory Committee reviewing Targiniq, an opioid that Purdue had been developing for several years. McKinsey consultants, including Mr. Smith, had",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "35a8fef7-4957-47c0-ab41-6063eda51577",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.2,
        "x": 0.15,
        "y": 0.89
      },
      "kind": "source-note",
      "text": "151 MCK-HCOR-0099021.",
      "attrs": {
        "numbered": true
      },
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "02bbcbc8-d5d3-4db0-b742-91be97d7bf3f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.7,
        "x": 0.15,
        "y": 0.11
      },
      "kind": "title",
      "text": "1. McKinsey Used FDA Experience to Win Business from Purdue’s CEO",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "923e64da-4c4b-43a3-bb44-4f3790a04c53",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 53,
      "from": 29,
      "beatId": "1170eac2-9202-4b41-a53c-edbd934ded10",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "The document concludes with implications of McKinsey's actions and potential next steps for regulatory action.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 53,
      "from": 1,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "ee9686db-f8b5-4bc9-bf6e-2d29966ee033",
      "evidence": "The document implies the cost of inaction through its presentation of McKinsey's conflicts of interest and their potential impact on the opioid epidemic.",
      "position": 0,
      "objective": "What is the cost of inaction in addressing McKinsey's conflicts of interest?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 40,
      "from": 24,
      "name": "Voice Of Customer",
      "slug": "51-voice-of-customer",
      "bestFor": "Product strategy, customer experience, market research",
      "matchId": "308c22ef-34f3-45b8-b50d-c273c6edeb88",
      "evidence": "The document presents the concerns of regulatory bodies through examples of McKinsey's actions and lack of disclosure.",
      "position": 1,
      "objective": "What are the concerns of regulatory bodies regarding McKinsey's conflicts of interest?",
      "structure": "What Customers Say (Verbatim) -> The Pattern Across Voices -> The Insight -> The Response",
      "confidence": 0.6,
      "description": "Let customer quotes and feedback drive the narrative and validate the insight"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}